tBid induces alterations of mitochondrial fatty acid oxidation flux by malonyl-CoA-independent inhibition of carnitine palmitoyltransferase-1
and Jayson Lusk, Professor, Vice President and Dean of Oklahoma State Universitys Division of Agricultural Sciences and Natural Resources.
GLP-1 side effects are often felt in the first few weeks of taking the drug or gradual dose increases, a process known as titration
The LEAD-6 head-to-head trial demonstrated greater HbA1c reduction (1.12% vs 0.79%), fewer hypoglycemia events, and better tolerability
doi: 10.3389/fnins.2025.1498981 Received 19 September 2024 Accepted 17 February 2025 Published 10 March 2025 Volume 19 - 2025 Edited by Nemanja Jovicic, University of Kragujevac, Serbia Reviewed by Lorenzo Lorusso, ASST Lecco, Italy Benjamin Heng, Macquarie University, Australia Hanneke Willemen, University Medical Center Utrecht, Netherlands Updates Copyright 2025 Davis, Higgs, Snaith, Lodge, Strong, Espejo-Oltra, Kujawski, Zalewski, Pretorius, Hoerger and Morten